Home › Essential Thrombocythemia › New York
Essential Thrombocythemia clinical trials in New York
7 studies for Essential Thrombocythemia are looking for participants at sites in New York.
Cities in New York
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- NYP/Weill Cornell Medical Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06661915A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College - Newyork-Presbyterian Hospita, New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07623200A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Icahn School of Medicine At Mount Sinai, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07008118Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06034002MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT07362225MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
- Ruttenberg Treatment Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT06541249From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.